WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

A securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS) for allegedly making false statements about the Fabric acquisition's impact on the company's financials and operational efficiencies. The lawsuit claims defendants knew of significant problems with Fabric's viability that would negatively impact the business. Investors with losses exceeding $100K are encouraged to join the class action before the August 3, 2026 lead plaintiff deadline.

08/01/2026, 11:27 AM • GlobeNewswire

מועד אחרון לתביעה הייצוגית נגד ב-WGS ביום שני: רוזן, יועץ מהימן למשקיעים, קורא למשקיעי GeneDx Holdings Corp שספגו הפסדים העולים על 100,000 דולר לקבל ייצוג משפטי לפני המועד החשוב ב-3 באוגוסט במסגרת תביעה ייצוגית בניירות ערך – WGS

Rosen Law Firm announces a securities class action lawsuit against GeneDx Holdings Corp (WGS) for alleged false statements regarding the Fabric acquisition. The firm claims GeneDx made misleading statements about cost reduction and operational synergies that never materialized, causing investor losses. The deadline to join the class action is August 3, 2026.

08/01/2026, 3:16 AM • GlobeNewswire

MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

GeneDx Holdings Corp. (WGS) investors with substantial losses have until August 3, 2026 to seek appointment as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that GeneDx made false and misleading statements regarding the viability of its Fabric Genomics acquisition. GeneDx's stock dropped over 49% on May 4, 2026 after revealing a significant drop in adjusted gross margin from 74% to 69%, reduced earnings projections, and a $31.3 million impairment loss directly attributable to Fabric Genomics.

07/31/2026, 6:55 AM • GlobeNewswire

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

GeneDx Holdings Corp. faces a securities class action lawsuit for failing to disclose material information between April 16, 2025 and May 4, 2026. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, lowered full-year guidance from $540-$550M to $475-$490M, and took a $31.2M impairment loss on its Fabric Genomics acquisition. GeneDx shares fell 49.2% on the announcement. Investors with losses exceeding $100,000 have until August 3, 2026 to file lead plaintiff applications.

07/30/2026, 11:48 AM • GlobeNewswire

WGS DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

Rosen Law Firm reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors who purchased stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant viability problems that would negatively impact the business.

07/29/2026, 10:30 PM • GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GeneDx Holdings Corp. faces a securities fraud class action lawsuit for failing to disclose material information about its Fabric Genomics acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and took a $31.2 million impairment loss, resulting in a 49.2% stock price decline. Investors who purchased shares between April 16, 2025 and May 4, 2026 can file lead plaintiff applications by August 3, 2026.

07/28/2026, 10:52 PM • GlobeNewswire

GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging the company made false statements about Fabric Genomics and overstated the durability of reimbursement rates. On May 4, 2026, GeneDx revealed a $57.5 million operational loss, lowered 2026 revenue guidance by $65 million, and took a $31.3 million write-down on Fabric Genomics. The stock price fell approximately 50% from $67.93 to $34.51 per share. Investors have until August 3, 2026 to apply as lead plaintiff.

07/27/2026, 6:11 PM • GlobeNewswire

WGS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

A securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS) for allegedly making false statements regarding the Fabric acquisition's impact on the company's financials and operations. Investors who purchased GeneDx common stock between April 16, 2025 and May 4, 2026 may be entitled to compensation. The deadline to serve as lead plaintiff is August 3, 2026.

07/26/2026, 1:15 PM • GlobeNewswire

WGS 9-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

A securities fraud class action has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging the company misled investors about the strategic and financial benefits of its Fabric Genomics acquisition. On May 4, 2026, GeneDx disclosed missed revenue estimates, slashed full-year guidance, and recorded a $31.2 million impairment charge on Fabric, causing the stock to plummet 49.2% in a single session. The lead plaintiff deadline is August 3, 2026.

07/25/2026, 8:06 PM • GlobeNewswire

WGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

A securities fraud class action has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging the company misled investors about the strategic and financial benefits of its Fabric Genomics acquisition. On May 4, 2026, GeneDx disclosed missed revenue estimates, slashed full-year guidance, and recorded a $31.2 million impairment charge on Fabric, causing the stock to plummet 49.2% in a single session. The lead plaintiff deadline is August 3, 2026.

07/24/2026, 2:37 PM • GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GeneDx Holdings Corp. faces a securities class action lawsuit for allegedly failing to disclose material information about its acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and disclosed a $31.2 million impairment loss on its Fabric Genomics acquisition. GeneDx shares fell 49.2% following the May 4, 2026 announcement, with the company lowering full-year revenue guidance from $540-$550 million to $475-$490 million.

07/21/2026, 10:24 PM • GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

Pomerantz Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. alleging securities fraud and unlawful business practices. The lawsuit stems from GeneDx's May 2026 announcement of disappointing Q1 results, including a significant drop in adjusted gross margin from 74% to 69%, reduced earnings guidance, and a $31.3 million impairment loss related to its Fabric Genomics acquisition. GeneDx's stock price fell 49.20% following the announcement.

07/21/2026, 12:55 PM • GlobeNewswire

WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Rosen Law Firm is reminding investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant problems that would negatively impact the business.

07/20/2026, 3:27 PM • GlobeNewswire

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026 to join a class action lawsuit alleging securities fraud. GeneDx revealed false and misleading statements regarding its Q1 2026 financial results, including a drop in adjusted gross margin, lowered earnings projections, and a $31.3 million impairment related to Fabric Genomics.

07/20/2026, 12:52 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging that the company made materially false and misleading statements regarding Fabric Genomics, reimbursement rates durability, and gross margins during the period from April 16, 2025 to May 4, 2026. Investors who purchased GeneDx securities during this period are encouraged to join the case, with a lead plaintiff deadline of August 3, 2026.

07/19/2026, 12:00 PM • GlobeNewswire